Dosimertinib-d3 - CAS 2403760-70-1

Dosimertinib-d3 is a potent, orally active inhibitor of EGFR, known to reduce the expression of p-EGFR and p-ERK proteins, thereby exhibiting antiproliferative and anti-tumor effects. It holds promise for research into non-small-cell lung cancer (NSCLC) .

EGFR

JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis

2403689

C28H28D5N7O2

504.64

C(N1C=C(C=2C1=CC=CC2)C3=NC(NC4=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C([2H])[2H])=O)=C4)=NC=C3)([2H])([2H])[2H]

-20°C

Ice Packs

Isotope products